ArticleCase reports in obstetrics and gynecology2026
Rare Metastatic Involvement of the Sigmoid Mesocolon by Low-Grade Endometrial Stromal Sarcoma.
Article in Case reports in obstetrics and gynecology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Endometrial stromal sarcoma (ESS) is an uncommon uterine malignancy with an indolent course and potential for late recurrence or metastasis. Extrauterine ESS is exceedingly rare, especially in the absence of a primary uterine lesion. Case Presentation: We present a case of a 50-year-old woman with low-grade ESS metastasizing to the sigmoid mesocolon. The patient underwent surgical resection followed by radical hysterectomy, bilateral salpingo-oophorectomy, and hormonal therapy with letrozole. After 5 years of follow-up, she remains disease-free. Discussion: This case underscores the importance of considering ESS in the differential diagnosis of mesocolon masses and highlights the role of combined surgical and hormonal therapy in achieving long-term remission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.